ANI Pharmaceuticals Stock Options
| ANIP Stock | USD 58.46 0.96 1.67% |
ANI Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 0.51 with a put-to-call open interest ratio of 0.7 over 21 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows ANI Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ANI Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ANI Pharmaceuticals' option, there is no secondary market available for investors to trade.
ANI Pharmaceuticals Maximum Pain Price Across 2025-04-17 Option Contracts
Max pain occurs when ANI Pharmaceuticals' market makers reach a net positive position across all ANI Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, ANI Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on ANI Pharmaceuticals
Analyzing ANI Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in ANI Pharmaceuticals regardless of its overall volatility. This is especially true when ANI Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ANI Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with ANI Pharmaceuticals' stock while costing only a fraction of its price.
ANI Pharmaceuticals In The Money Call Balance
When ANI Pharmaceuticals' strike price is surpassing the current stock price, the option contract against ANI Pharmaceuticals stock is said to be in the money. When it comes to buying ANI Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ANI Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
ANI Current Options Market Mood
ANI Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ANI Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most ANI Pharmaceuticals' options investors are not very successful. ANI Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current ANI contract
Base on the Rule 16, the options market is currently suggesting that ANI Pharmaceuticals will have an average daily up or down price movement of about 0.0319% per day over the life of the 2025-04-17 option contract. With ANI Pharmaceuticals trading at USD 58.46, that is roughly USD 0.0186. If you think that the market is fully incorporating ANI Pharmaceuticals' daily price movement you should consider buying ANI Pharmaceuticals options at the current volatility level of 0.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
ANI |
Purchasing ANI Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ANI calls. Remember, the seller must deliver ANI Pharmaceuticals stock to the call owner when a call is exercised.
ANI Pharmaceuticals Option Chain
When ANI Pharmaceuticals' strike price is surpassing the current stock price, the option contract against ANI Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ANI Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on ANI. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ANI. It also shows strike prices and maturity days for a ANI Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ANIP250417C00045000 | 0 | 45.0 | 12.5 - 17.0 | 12.5 | In |
Call | ANIP250417C00050000 | 0 | 50.0 | 8.0 - 12.2 | 8.0 | In |
Call | ANIP250417C00055000 | 15 | 55.0 | 4.0 - 8.0 | 10.21 | In |
Call | ANIP250417C00060000 | 24 | 60.0 | 1.8 - 5.4 | 2.5 | Out |
Call | ANIP250417C00065000 | 4 | 65.0 | 0.4 - 4.8 | 3.0 | Out |
Call | ANIP250417C00070000 | 36 | 70.0 | 0.5 - 1.65 | 2.0 | Out |
Call | ANIP250417C00075000 | 1 | 75.0 | 0.0 - 4.8 | 1.5 | Out |
Call | ANIP250417C00080000 | 2 | 80.0 | 0.0 - 4.8 | 0.9 | Out |
Call | ANIP250417C00085000 | 1 | 85.0 | 0.0 - 4.8 | 0.9 | Out |
Call | ANIP250417C00090000 | 1 | 90.0 | 0.0 - 4.8 | 0.6 | Out |
Put | ANIP250417P00040000 | 1 | 40.0 | 0.0 - 4.8 | 0.9 | Out |
Put | ANIP250417P00045000 | 0 | 45.0 | 0.15 - 4.9 | 0.15 | |
Put | ANIP250417P00050000 | 27 | 50.0 | 0.1 - 2.6 | 1.5 | Out |
Put | ANIP250417P00055000 | 30 | 55.0 | 0.3 - 4.9 | 3.6 | Out |
Put | ANIP250417P00060000 | 1 | 60.0 | 2.9 - 6.5 | 6.2 | In |
Put | ANIP250417P00065000 | 0 | 65.0 | 5.8 - 10.0 | 5.8 | In |
Put | ANIP250417P00070000 | 0 | 70.0 | 10.5 - 14.0 | 10.5 | In |
Put | ANIP250417P00075000 | 0 | 75.0 | 14.8 - 19.0 | 15.6 | In |
Put | ANIP250417P00080000 | 0 | 80.0 | 19.8 - 24.0 | 19.8 | In |
Put | ANIP250417P00085000 | 0 | 85.0 | 24.2 - 29.0 | 24.2 | In |
Put | ANIP250417P00090000 | 0 | 90.0 | 29.2 - 34.0 | 29.2 | In |
ANI Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
ANI Total Stockholder Equity
Total Stockholder Equity |
|
ANI Pharmaceuticals Corporate Management
| Meredith Cook | General VP | Profile | |
| Elizabeth JD | Chief Disease | Profile | |
| Krista Davis | Senior Officer | Profile | |
| Muthusamy RPh | COO RD | Profile | |
| Thomas Rowland | Senior Brands | Profile |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.